Myrexis (OTCPK:MYRX) - Stock Price, News & Analysis

MYRX Stock Overview

Focuses on identifying, evaluating, and making financial investments in life sciences assets. More details

MYRX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($241K)

Shares are highly illiquid

Myrexis, Inc. Competitors

NexImmune

OTCPK:NEXI

US$571.8k

TC Biopharm (Holdings)

NasdaqCM:TCBP

US$328.8k

Capstone Holding

OTCPK:CAPS

US$504.4k

Allena Pharmaceuticals

OTCPK:ALNA.Q

US$109.9k

Price History & Performance

Summary of all time highs, changes and price drops for Myrexis
Historical stock prices
Current Share Price	US$0.007
52 Week High	US$0.019
52 Week Low	US$0.001
Beta	0
11 Month Change	0%
3 Month Change	6.06%
1 Year Change	27.27%
33 Year Change	-65.17%
5 Year Change	-69.57%
Change since IPO	-99.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	MYRX	US Biotechs	US Market
7D	0%	2.4%	0.5%
1Y	27.3%	15.6%	30.7%

Return vs Industry: MYRX exceeded the US Biotechs industry which returned 15.6% over the past year.

Return vs Market: MYRX underperformed the US Market which returned 30.7% over the past year.

Price Volatility

Is MYRX's price volatile compared to industry and market?
MYRX volatility
MYRX Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: MYRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MYRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Jon Couchman	www.myrexis.com

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Myrexis, Inc. Fundamentals Summary

How do Myrexis's earnings and revenue compare to its market cap?
MYRX fundamental statistics
Market cap	US$241.35k
Earnings (TTM)	-US$11.62m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is MYRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MYRX income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$11.62m
Earnings	-US$11.62m

Last Reported Earnings

Jun 30, 2013

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MYRX perform over the long term?

See historical performance and comparison